Unlike a sanctioned clinical trial (where experimental drugs can be used under careful monitoring and informed consent under an FDA Investigational New Drug protocol), offering BPC-157 in routine practice amounts to experimenting on the patient without oversight
Therefore, our awareness currently must be on monitoring new drugs which could provide a putative alternative to the current duopoly (as well as drugs that could reinforce the duopoly by resulting in either NVO or LLY or both having an oral alternative)
doi: 10.1016/0304-4165(90)90147-O
The collection includes the NAD+ Boost, featuring the NAD+ precursor ingredient, which helps boost energy metabolism and cellular vitality
The key is to identify what works for YOU
GHK-Cu modulates broad genetic programs, suppresses NF-B , supports DNA repair and proteasomal functions , reducing ROS and cytokines